(Circulation. 1995;92:142-147.)
© 1995 American Heart Association, Inc.
Articles |
Genetic Approaches to Cardiovascular Disease
Supravalvular Aortic Stenosis, Williams Syndrome, and Long-QT syndrome
From the Howard Hughes Medical Institute, Eccles Institute of Human Genetics, and Cardiology Division, University of Utah Health Sciences Center, Salt Lake City.
Correspondence to Dr Mark Keating, Eccles Institute of Human Genetics, University of Utah, Building 533, Room 2100, Salt Lake City, UT 84112.
Background Although family history can be an important risk factor for cardiovascular disease, relatively little is known about the nature of specific genetic risk factors. One approach to this problem is to identify and characterize genes responsible for inherited disorders in the hope that this information will also provide mechanistic insight into common forms of cardiovascular disease.
Methods and Results Over the last decade, it has become possible to identify genes that cause human disease by use of the techniques of molecular genetics, specifically genetic linkage analysis, positional cloning, and mutational analyses. We have used these techniques to study three inherited cardiovascular disorders: supravalvular aortic stenosis, Williams syndrome, and long-QT syndrome. We have discovered that the vascular pathology of supravalvular aortic stenosis and Williams syndrome results from mutations involving the elastin gene on chromosome 7q11.23. These mutations include intragenic deletions, translocations, and complete deletion of the elastin gene, suggesting that a quantitative reduction in elastin during vascular development is pathogenically important. To date, only the elastin gene has proved important for supravalvular aortic stenosis. By contrast, genetic linkage analyses in families with long-QT syndrome indicate that at least four distinct genes can cause this disorder. We have identified three LQT loci: LQT1 on chromosome 11p15.5, LQT2 on 7q35-36, and LQT3 on 3p21-24. Recently, we demonstrated that mutations in a putative cardiac potassium channel gene, HERG, are responsible for the chromosome 7–linked form of long-QT syndrome, whereas mutations in the cardiac sodium channel gene SCN5A cause the chromosome 3–linked form of this disorder. HERG mutations and potassium channel biophysics suggest a dominant-negative molecular mechanism and reduced repolarization currents. By contrast, SCN5A mutations probably cause subtle alterations of cardiac sodium channel function and prolonged depolarizing currents.
Conclusions Molecular genetic analyses of long-QT syndrome, supravalvular aortic stenosis, and Williams syndrome have begun to unravel the mechanisms underlying these inherited disorders. Rapid genetic testing for Williams syndrome is now available using a simple cytogenetic test, fluorescence in situ hybridization, but additional work will be required for long-QT syndrome and autosomal-dominant supravalvular aortic stenosis. Improved diagnosis and mechanistic understanding of these disorders should lead to rational treatment and prevention.
Key Words: arrhythmias • stenosis • genes
This article has been cited by other articles:
 |
|
 |
|
  J. Aboulhosn and J. S. Child Left Ventricular Outflow Obstruction: Subaortic Stenosis, Bicuspid Aortic Valve, Supravalvar Aortic Stenosis, and Coarctation of the Aorta Circulation, November 28, 2006; 114(22): 2412 - 2422. [Full Text] [PDF]
|
|
|
|
 |
|
 M Eronen, M Peippo, A Hiippala, M Raatikka, M Arvio, R Johansson, and M Kahkonen Cardiovascular manifestations in 75 patients with Williams syndrome J. Med. Genet., August 1, 2002; 39(8): 554 - 558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stamm, I. Friehs, S. Y. Ho, A. M. Moran, R. A. Jonas, and P. J. del Nido Congenital supravalvar aortic stenosis: a simple lesion? Eur. J. Cardiothorac. Surg., February 1, 2001; 19(2): 195 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Thistlethwaite, M. M. Madani, J. M. Kriett, K. Milhoan, and S. W. Jamieson Surgical management of congenital obstruction of the left main coronary artery with supravalvular aortic stenosis J. Thorac. Cardiovasc. Surg., December 1, 2000; 120(6): 1040 - 1046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. C. Dorostkar, M. Eldar, B. Belhassen, and M. M. Scheinman Long-Term Follow-Up of Patients With Long-QT Syndrome Treated With {beta}-Blockers and Continuous Pacing Circulation, December 14, 1999; 100(24): 2431 - 2436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stamm, C. Kreutzer, D. Zurakowski, G. Nollert, I. Friehs, J. E. Mayer, R. A. Jonas, and P. J. del Nido FORTY-ONE YEARS OF SURGICAL EXPERIENCE WITH CONGENITAL SUPRAVALVULAR AORTIC STENOSIS J. Thorac. Cardiovasc. Surg., November 1, 1999; 118(5): 874 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sauvage, M. Osborne-Pellegrin, F. D.-L. Flohic, and M. P. Jacob Influence of Elastin Gene Polymorphism on the Elastin Content of the Aorta : A Study in 2 Strains of Rat Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2308 - 2315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-C. Zhang, L. He, M. Giro, S. L. Yong, G. E. Tiller, and J. M. Davidson Cutis Laxa Arising from Frameshift Mutations in Exon 30 of the Elastin Gene (ELN) J. Biol. Chem., January 8, 1999; 274(2): 981 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Nelson, E. A. Sparks, H. L. Graber, H. Boudoulas, A. A. Mehdirad, P. Baker, and C. Wooley Clinical characteristics of sudden death victims in heritable (chromosome 1p1-1q1) conduction and myocardial disease J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1717 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Maron, J. H. Moller, C. E. Seidman, G. M. Vincent, H. C. Dietz, A. J. Moss, J. A. Towbin, H. M. Sondheimer, R. E. Pyeritz, G. McGee, et al. Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome : A Statement for Healthcare Professionals From the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association Circulation, October 6, 1998; 98(14): 1460 - 1471. [Full Text] [PDF]
|
|
|
|
|
|
J. Kiehn, C. Karle, D. Thomas, X. Yao, J. Brachmann, and W. Kubler HERG Potassium Channel Activation Is Shifted by Phorbol Esters via Protein Kinase A-dependent Pathways J. Biol. Chem., September 25, 1998; 273(39): 25285 - 25291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Grahame-Clarke, W B Pugsley, and R H Swanton Supravalvar aortic stenosis: unexpected findings at surgery Heart, June 1, 1998; 79(6): 627 - 628. [Full Text]
|
|
|
|
 |
|
 S. Nattel Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs Cardiovasc Res, March 1, 1998; 37(3): 567 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stamm, J. Li, S. Y. Ho, A. N. Redington, and R. H. Anderson THE AORTIC ROOT IN SUPRAVALVULAR AORTIC STENOSIS: THE POTENTIAL SURGICAL RELEVANCE OF MORPHOLOGIC FINDINGS J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 16 - 24. [Abstract] [Full Text]
|
|
|
|
|
|
J. Kiehn, A. E. Lacerda, B. Wible, and A. M. Brown Molecular Physiology and Pharmacology of HERG: Single-Channel Currents and Block by Dofetilide Circulation, November 15, 1996; 94(10): 2572 - 2579. [Abstract] [Full Text]
|
|
|
|
|
|
A. A. Grace and K. R. Chien Congenital Long QT Syndromes : Toward Molecular Dissection of Arrhythmia Substrates Circulation, November 15, 1995; 92(10): 2786 - 2789. [Full Text]
|
|